Test automation for the business journeys your releases depend on

Your engineers finish a change, then the team repeats the same checks before shipping: sign in, create a record, approve it, confirm the result. As the product grows, the checks multiply. An existing automation suite can create another problem if failures take too long to investigate or nobody owns updates.

Our proposed starting point is one release-critical journey. Define what must remain true, how to establish the starting data and what evidence would justify trusting the result. Expand coverage once the team can run and maintain that first slice.

We would begin by reviewing your application, repository, release workflow and existing tests. Together, we select the business behavior to cover and identify the dependencies that could make the result unreliable.

The implementation scope can include browser checks for user interactions, API checks for rules and persisted state, controlled test-data setup, and integration with your existing CI pipeline. Framework selection follows the application and your team's maintenance needs. Playwright is one option for web applications; a framework migration is not an automatic requirement.

The deliverable is a repository-owned suite with a coverage ledger, run instructions, failure evidence and agreed maintenance responsibilities. The proposal names supported browsers, environments and integrations. It also records what remains manual or outside scope.

The example below is a proposed design for an invoice approval workflow. It is not a customer result or a demonstration of an implemented suite.

This ledger makes coverage reviewable. Each row has a starting state, expected result, test location and owner. A test count alone cannot show whether the important transaction is covered.

Tests need a predictable starting point. We would agree how synthetic accounts and records are created, isolated and cleaned up. Browser sessions can be independent while still sharing backend records, so data ownership needs explicit design.

Playwright's best-practices guide recommends independent tests and checks of user-visible behavior. These principles inform the browser portion of the approach. External dependencies need a separate decision: simulation gives control, while sandbox checks exercise a different integration boundary. A simulated provider response cannot establish that the provider integration works.

The suite should run on the CI environment your team will operate. Acceptance includes its setup, reports and failure investigation path. Playwright's CI documentation describes the browser dependencies required for that execution.

A passing retry should remain distinguishable from an initial pass. Playwright documents these outcomes separately. We would agree how intermittent failures are recorded, investigated and escalated rather than treating a retry as a repair.

For each quarantined check, record the uncovered behavior, temporary manual verification, owner and review date. Define responsibility for product changes, test defects and environment failures in the engagement. Ongoing suite maintenance can be scoped separately from initial implementation; neither should be left implicit.

At handover, an internal engineer should be able to run the suite, investigate a controlled failure and update a check after an agreed small product change. That exercise gives the team a concrete way to accept the work.

This offer fits an existing web product with repository access, a usable test environment and someone who can approve the expected business behavior. It can also fit an existing suite that needs a focused stabilization pass before new coverage is added.

If business rules are unresolved or the environment cannot be reset safely, the first scope should address those constraints. Automating uncertain behavior makes the uncertainty harder to see.

Functional regression coverage does not establish security, accessibility, performance or regulatory compliance. Native mobile and specialized platform testing require separate scoping. There is no promise of a defect-free product, a fixed coverage percentage or a release-time improvement without a measured baseline.